Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SENSIPAR vs SILTUXIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SENSIPAR vs SILTUXIMAB: Safety Overview

Metric SENSIPAR SILTUXIMAB
Total FAERS Reports 577 472
Deaths Reported 82 89
Death Rate 14.2% 18.9%
Hospitalizations 52 145
Average Patient Age 62.8 yrs 47.4 yrs
% Female Patients N/A 56.9%
Manufacturer N/A Recordati Rare Diseases, Inc.
Route N/A INTRAVENOUS
Marketing Status N/A Prescription